The Exchange had sought clarification from Sun Pharmaceutical Industries with respect to news article appearing in Mint on August 31, 2015 titled ‘Sun, Wockhardt recall drugs from US’. Sun Pharmaceutical Industries replied stating that they hereby confirm that it is the voluntary recall initiated by their Company for certain stated medicines. They further state that it has no/would have no material impact on Company’s performance, operations or revenues.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.20 |
| Dr. Reddys Lab | 1235.00 |
| Cipla | 1232.20 |
| Zydus Lifesciences | 936.50 |
| Lupin | 2331.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: